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Conclusions: Despite the high degree of sequence 
homology to ALS.5, the ALS6 and ALS7 genes of C. 
albicans do not mediate adherence to fibronectin. These 
functional differences despite sequence homology have 
allowed us to produce chimeric ALS genes, and thereby 
localize the fibronectin-binding domain of ALS.5 to the 
N-terminal portion of the gene product. This technique 
will be invaluable in further defining the key binding 
domain of the Als5 protein, a critical initial step in the 
development of novel therapeutics targeted at the 
inhibition of candidal adherence. 
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Geotrichum is a ubiquitous fungus distinctive for 
arthrocondia and septated hyphae. It is present in soil, 
fruits and dairy products and is a markedly rare human 
systemic pathogen with a reported mortality rate of 
70-75 %. We present a neutropenic 64-year male patient 
with CLL treated since mid 2001 with fludarabine based 
chemotherapy and prophylactic tmp/smz who was re- 
admitted for fungemia in February 2002. 
The patient’s complex illness included four cycles of 
chemotherapy, and hospitalizations the prior September 
and December for neutropenic fever with an absolute 
neutrophil count (ANC) less than 200 on both admissions. 
During the December admission a biopsy of a left thigh 
lesion grew Nocardia brusiliensis that was treated with 
appropriate intravenous and then outpatient oral 
therapy. In January 2002, complaining on this occasion 
of right lower leg swelling and pain, the patient was 
readmitted with an ANC of zero. Chemotherapeutic 
coverage for Nocardia was in-tensified and robust anti- 
biotic management for neutropenia administered. After 
more than a fortnight of inpatient management, the 
patient was afebrile and was discharged on outpatient 
antibiotics. Within two days of discharge, the lab reported 
fungemia. 
On prompt readmission intensive antibacterial and 
antifungal therapy was given. One-day post admission 
the blood culture isolate was identified as Geotrichum. 
Imaging revealed multiple lesions in the soft tissues and 
musculature of both 1egs.A cystic area of the right lower 
leg was debrided twice and grew Geotrichum on each 
occasion. A literature search found some relevant 
papers. A 12-year survey of unusual fungal infections at 
M D Anderson cancer center reported 2 patients with 
Geotrichum infections. Neither patient survived. A lo- 
year survey at a tertiary hospital in Bergamo, Italy 
identified 3 cases of Geotrichum with no survivors. 
One antifungal sensitivity study reported MIC’s for 
amphotericin B of 0.39 at 50% and 0.78 at 90% while 
another study reported voriconazole MIC’s of 0.20 at 
50% and 0.39 at 90%. Our patient’s initial antifungal 
therapy of Abelcet and itraconazole was changed to 
Abelcet, caspofungin and voriconazole and was later 
modified to AmBisome, caspofungin, voriconazole and 
flucy-tosine. Neutrophil production was stimulated with 
G-CSF and then, based on a published 3 patient case 
series report, with GM-CSF. Blood cultures have 
become sterile, but the patient has shown little clinical 
progress. The Geotrichum isolate has been forwarded to 
research labs for further testing against comprehensive 
panels of antifungals including the emerging azoles. Our 
patient resolutely continues to re-quest aggressive treat- 
ment for this unusual pathogen. The result of this novel 
therapy against his dire infection remains in question. 
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The fatality rate associated with central nervous system 
(CNS) aspergillosis (Asp) in immunocompromised 
patients is high and often established by autopsy. We 
report 2 patients who were rapidly diagnosed and 
treated for CNS Asp and are longtime survivors. Patient 
1, a 19-year-old male, was diagnosed as having bone 
marrow failure 2 years prior to Ewing’s sarcoma, at 
humerus. He had received TBI. chemotherapy, ATG 
prior to cord blood transplant. Acute mental status 
changes led to an MRl showing multiple ring enhancing 
lesions (MREL). Brain diagnosis (dx) showed A. fumi- 
gatus.The patient received prolonged amphotericin B & 
5-FC and GMCSF. He is now 40 months from CNS Asp. 
Imaging, neuro exam, and bone marrow are normal. He 
attends vocational school. Patient 2, an H-year-old male 
with acute lymphoblastic leukemia had 4 weeks of 
induction therapy when fever and cough led to a CT 
scan (chest) showing multiple lung nodules. CT scan 
brain showed MREL. Open lung biopsy and craniotomy 
with drainage showed Asp, all tissues. He received 
prolonged amphotericin B lipid complex, 5-FC and 
modified ALL therapy. Thirty months after dx Asp, 
imaging and neuro exam are normal; his ALL is in 
remission. He attends high school. With high clinical 
suspicion, rapid use of imaging - expeditious employ- 
ment of surgery, prolonged administration of antifungals 
and maintaining adequate phagocyte counts, the out- 
come of CNS Asp can be improved. 
